| Calix Limited (CXL) ORDINARY FULLY PAID |
Materials |
$103 |
Application for quotation of securities - CXL
|
24 Jun 2025 12:18PM |
$0.320 |
$0.480 |
risen by
50%
|
|
| Prospect Resources Limited (PSC) ORDINARY FULLY PAID |
Materials |
$135 |
Notice of Long Equity Derivative Position
|
24 Jun 2025 12:13PM |
$0.163 |
$0.193 |
risen by
18.46%
|
|
| Terrain Minerals Limited (TMX) ORDINARY FULLY PAID |
Materials |
$8 |
Form 603 Director Initial Substantial holder (Mr J Virgin)
|
24 Jun 2025 12:00PM |
$0.002 |
$0.003 |
risen by
50%
|
|
| Terrain Minerals Limited (TMX) ORDINARY FULLY PAID |
Materials |
$8 |
Appendix 3Y - Johannes Lin
|
24 Jun 2025 11:57AM |
$0.002 |
$0.003 |
risen by
50%
|
|
| Greatland Resources Limited (GGP) ORDINARY FULLY PAID |
Materials |
$3,407 |
Resignation and Appointment of Auditor
|
24 Jun 2025 11:57AM |
$5.080 |
$5.080 |
fallen by
0%
|
|
| Terrain Minerals Limited (TMX) ORDINARY FULLY PAID |
Materials |
$8 |
Appendix 3Y - Jason Macdonald
|
24 Jun 2025 11:57AM |
$0.002 |
$0.003 |
risen by
50%
|
|
| Terrain Minerals Limited (TMX) ORDINARY FULLY PAID |
Materials |
$8 |
Appendix 3Y - Justin Virgin
|
24 Jun 2025 11:56AM |
$0.002 |
$0.003 |
risen by
50%
|
|
| Terrain Minerals Limited (TMX) ORDINARY FULLY PAID |
Materials |
$8 |
Notification regarding unquoted securities - TMX
|
24 Jun 2025 11:53AM |
$0.002 |
$0.003 |
risen by
50%
|
|
| Terrain Minerals Limited (TMX) ORDINARY FULLY PAID |
Materials |
$8 |
Application for quotation of securities - TMX
|
24 Jun 2025 11:53AM |
$0.002 |
$0.003 |
risen by
50%
|
|
| Terrain Minerals Limited (TMX) ORDINARY FULLY PAID |
Materials |
$8 |
Issue of Shares and Options
|
24 Jun 2025 11:52AM |
$0.002 |
$0.003 |
risen by
50%
|
|
| Paterson Resources Ltd (PSL) ORDINARY FULLY PAID |
Materials |
$9 |
Becoming a substantial holder
|
24 Jun 2025 11:50AM |
$0.015 |
$0.019 |
risen by
26.67%
|
|
| Biotron Limited (BIT) ORDINARY FULLY PAID |
Health Care |
$5 |
Hepatitis B Virus Program Update
|
24 Jun 2025 11:49AM |
$0.002 |
$0.004 |
risen by
100%
|
|
BIT - Price-sensitive ASX Announcement
Full Release
Key Points
- Biotron Limited’s lead HBV program centers on the drug candidate BIT225.
- BIT225 has a novel dual mechanism, affecting both viral replication and immune modulation.
- Completed Phase 2a trial showed BIT225 was effective and well-tolerated in chronic HBV patients.
- BIT225 showed reduction in viral markers and positive clinical signals.
- There is a significant unmet need for new HBV therapies achieving a functional cure.
- Biotron is advancing BIT225 into later-stage clinical trials and planning regulatory interactions.
- The company is seeking partnerships for global development of BIT225.
- The report highlights BIT225’s potential as a first-in-class therapy for chronic HBV.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Babylon Pump & Power Limited (BPP) ORDINARY FULLY PAID |
Industrials |
$27 |
Application for quotation of securities - BPP
|
24 Jun 2025 11:47AM |
$0.005 |
$0.007 |
risen by
40%
|
|
| Adherium Limited (ADR) ORDINARY FULLY PAID |
Health Care |
$9 |
Proposed issue of securities - ADR
|
24 Jun 2025 11:37AM |
$0.007 |
$0.005 |
fallen by
28.57%
|
|
| Alternative Investment Trust (AIQ) ORDINARY UNITS FULLY PAID |
Financials |
$54 |
AIQ NTA Factsheet May 2025
|
24 Jun 2025 11:31AM |
$1.830 |
$1.700 |
fallen by
7.10%
|
|
| DTI Group Limited (DTI) ORDINARY FULLY PAID |
Information Technology |
$7 |
Application for quotation of securities - DTI
|
24 Jun 2025 11:22AM |
$0.005 |
$0.008 |
risen by
60%
|
|
| DTI Group Limited (DTI) ORDINARY FULLY PAID |
Information Technology |
$7 |
Results of Entitlement Offer
|
24 Jun 2025 11:16AM |
$0.005 |
$0.008 |
risen by
60%
|
|
DTI - Price-sensitive ASX Announcement
Full Release
Key Points
- DTI Group Limited completed an Entitlement Offer to its shareholders.
- The offer allowed eligible shareholders to acquire additional shares.
- The results indicate the amount of shares taken up and the shortfall.
- A summary of the funds raised and changes to share capital are provided.
- Management will handle the shortfall in accordance with the offer terms.
- DTI thanks shareholders for their participation and support.
- The company reaffirms its commitment to stakeholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fiducian Group Limited (FID) ORDINARY FULLY PAID |
Financials |
$361 |
Appendix 3Y - Change of Director's Interest - SH
|
24 Jun 2025 11:15AM |
$9.250 |
$11.430 |
risen by
23.57%
|
|
| Adherium Limited (ADR) ORDINARY FULLY PAID |
Health Care |
$9 |
Prospectus
|
24 Jun 2025 11:14AM |
$0.007 |
$0.005 |
fallen by
28.57%
|
|
ADR - Price-sensitive ASX Announcement
Full Release
Key Points
- The prospectus is for an offer of fully paid ordinary shares in Adherium Limited.
- Adherium Limited develops digital health solutions, focusing on respiratory health and medication adherence.
- The company offers proprietary digital sensors and cloud-connected platforms for monitoring patient inhaler use.
- ADR (American Depositary Receipts) are discussed as a means for foreign investors to hold shares.
- Funds raised will be used for product development, commercialization, and working capital.
- The prospectus outlines market opportunities in asthma and COPD management.
- Key risks include regulatory, clinical, technological, product, financial, and market risks.
- The document provides details on the board of directors, corporate governance, and management structure.
- Financial statements and forecasts are included, highlighting current financial position and funding needs.
- The offer is subject to regulatory, ASX listing, and investor eligibility requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rio Tinto Limited (RIO) ORDINARY FULLY PAID |
Materials |
$42,114 |
Investment of $1.6 billion to develop Hope Downs 2 project
|
24 Jun 2025 11:12AM |
$104.000 |
$113.450 |
risen by
9.09%
|
|
| Benz Mining Corp (BNZ) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$195 |
Accelerated Exploration Efforts at Glenburgh Gold Project
|
24 Jun 2025 11:09AM |
$0.410 |
$1.150 |
risen by
180.49%
|
|
| Xanadu Mines Limited (XAM) ORDINARY FULLY PAID |
Materials |
$183 |
Takeover Offer for Xanadu Declared Unconditional
|
24 Jun 2025 11:08AM |
$0.080 |
$0.080 |
risen by
0.63%
|
|
XAM - Price-sensitive ASX Announcement
Full Release
Key Points
- The takeover offer for Xanadu Mines Limited by Zijin Mining Group has become unconditional.
- All conditions for the offer have either been satisfied or waived.
- Xanadu's Board unanimously recommends shareholders accept the offer in the absence of a superior proposal.
- The offer provides shareholders with certainty of value and liquidity for their investment.
- Zijin Mining Group is a major international mining company with strong financial resources.
- The offer is for all shares not already owned by Zijin, with a clear timeline provided for acceptance.
- Shareholders who accept the offer will be paid within 7 business days of acceptance.
- The document outlines the risks of not accepting the offer, including potential share price decline and reduced liquidity.
- Frequently asked questions and answers are provided to assist shareholders’ decision-making.
- The takeover supports the development of Xanadu's Kharmagtai copper-gold project in Mongolia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Air New Zealand Limited (AIZ) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Industrials |
$1,751 |
Notice of share buyback
|
24 Jun 2025 11:03AM |
$0.530 |
$0.530 |
fallen by
0%
|
|
| Adherium Limited (ADR) ORDINARY FULLY PAID |
Health Care |
$9 |
Accel Non-Renounceable Entitlement Offer to raise up to $4m
|
24 Jun 2025 10:56AM |
$0.007 |
$0.005 |
fallen by
28.57%
|
|
ADR - Price-sensitive ASX Announcement
Full Release
Key Points
- Adherium Limited is undertaking an accelerated non-renounceable entitlement offer to raise up to AUD 4 million.
- The offer gives eligible shareholders the right to subscribe for new shares in proportion to their existing holdings.
- Proceeds from the offer will be used for working capital, product development, and commercialization.
- The offer aims to support the continued expansion of Adherium's respiratory monitoring products.
- Details include eligibility, offer timetable, and risk factors associated with the investment.
- Shareholders can apply for additional shares if some entitlements are not taken up.
- The offer is not renounceable, meaning entitlements cannot be sold or transferred.
- The document provides a detailed explanation of the reasons for the capital raise and its expected impact on the company.
- The capital raised is expected to fund ongoing operations and support further market expansion.
- Risks associated with the offer and Adherium's operations are disclosed for investor awareness.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lithium Universe Limited (LU7) ORDINARY FULLY PAID |
Materials |
$10 |
Change of Management Role
|
24 Jun 2025 10:53AM |
$0.007 |
$0.008 |
risen by
14.29%
|
|
LU7 - Price-sensitive ASX Announcement
Full Release
Key Points
- Mr. Iggy Tan steps down as Chairman of Lithium Universe Limited (LU7), effective immediately.
- Mr. Tan will continue to serve on the Board as a Non-Executive Director.
- Mr. Warren Hallam is appointed as the new Chairman of LU7.
- The company expresses gratitude for Mr. Tan's significant role and leadership.
- The management changes align with strategic plans to strengthen the company.
- These changes are effective from 12 June 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
